(Q34527165)

English

Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

type-1 diabetes

0 references

object named as

John Lachin

4

0 references

author name string

Maria F Lopes-Virella

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Kelly J Hunt

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Nathaniel L Baker

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

David M Nathan

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

G Virella

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

27 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

60

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

582-589

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

copyright license

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

30 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Adaptive immunity and atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

Atherogenesis and the humoral immune response to modified lipoproteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

Development of capture assays for different modifications of human low-density lipoprotein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

Lipoprotein autoantibodies: measurement and significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

Inflammation in atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

Atherosclerosis — An Inflammatory Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

Biochemistry of the arterial wall in developing atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

Minimally modified low density lipoprotein is biologically active in vivo in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

Human antibody effector function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

7 July 2018

Structural difference in the complement activation site of human IgG1 and IgG3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

27 October 2018

Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

27 October 2018

Autoimmune response to advanced glycosylation end-products of human LDL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

27 October 2018

The role of carotid arterial intima-media thickness in predicting clinical coronary events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

27 October 2018

Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

27 October 2018

Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028359

27 October 2018

Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation and characterization of human antioxidized LDL autoantibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study. The DCCT Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2337/DB10-0915

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34527165&oldid=1869911402"